News & Events

10/24/14   First Mary M. Kontos Award Presented to Two Outstanding Clinicians and Mentors
10/23/14   CF Care Centers Recognized for Commitment to Excellence
10/22/14   CF Foundation Honors Four for Work on Hypertonic Saline
10/22/14   FDA Panel Recommends Approval of Ivacaftor for People with R117H Mutation of CF
10/21/14   Videos of NACFC 2014 Plenary Sessions Available Online
10/17/14   Young Professionals Raise Nearly $140,000 to Benefit the CF Foundation
10/16/14   Sam’s Club Recalls Simply Right Baby Wipes Because of Possible Contamination with Bacteria B. Cepacia
10/14/14   New York Giants' Josh Brown Invites Fans to “help kick CF”
10/10/14   First Day of North American CF Conference Highlights Progress Since Discovery of CF Gene
10/09/14   World’s Largest Cystic Fibrosis Medical Conference Kicks Off in Atlanta
10/08/14   Insurance Coverage Remains a Top Concern for People with Cystic Fibrosis
09/29/14   2014 Great Strides, Great Stories - Team Superman
09/25/14   OneRepublic Features Teen with Cystic Fibrosis in New Music Video
09/23/14   Register to Watch Select Live Sessions from NACFC
09/15/14   CF Care Centers Advocate for Access to Enzymes in Michigan Medicaid
09/04/14   Physician Highlights Needs of People with CF in Congressional Roundtable
08/28/14   2014 Great Strides, Great Stories - Team Megan
08/18/14   Climbing Higher and Higher: Volunteers Raise $144,000 to Support CF Foundation’s Mission
08/06/14   Record Setting $1.2 Million Raised at CF Foundation’s Pipeline to a Cure
07/31/14   Vertex Announces Phase 2 Results of Combination Treatment in People with One Copy of the F508del CF Mutation
07/22/14   CF Foundation Provides New Health Education Resources on Infection Prevention and Control for CF Community
07/11/14   CF Foundation Featured at Congressional Hearing on Patients’ Involvement in Drug Development
07/02/14   Updated Infection Prevention and Control Guidelines for Cystic Fibrosis Now Published Online
07/01/14   CF Foundation Teen Advocates Share Their CF Stories with Members of Congress
06/24/14   Phase 3 Combination Studies of Ivacaftor (Kalydeco) and Lumacaftor (VX-809) Show Positive Results in Most Common CF Mutation
(1 to 25 of 50 News Items)    Result Page:  1 2 Next